A Multi-national, Non-interventional Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia
Latest Information Update: 20 Jan 2026
At a glance
- Drugs Bempedoic acid (Primary) ; Bempedoic acid/ezetimibe (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia
- Focus Adverse reactions
- Acronyms Musashi
- Sponsors Daiichi Sankyo Inc
Most Recent Events
- 24 Dec 2025 Planned initiation date changed from 30 Nov 2025 to 30 Jan 2026.
- 07 Oct 2025 New trial record